Monica Coleman

Executive Officer at Chimeron Bio.

Raised on Chimeron Bio filings

$12.8M

across 1 Form D filing

Form D filings: 1
Teammates: 3
Last filing: Mar 14, 2025

Company

Biotech · Philadelphia, PA

Self-amplifying RNA medicines and vaccines

Self-amplifying RNA medicines and vaccines

Investors: 9

Investors: 9
Sector: Biotech
HQ: Philadelphia, PA

Chimeron Bio filings

Chimeron Bio Form D filings
Filed	Security	Sold of offered	Filing
Mar 14, 2025	Equity	$12.8M/ no target	Form D/A

EquityFiled Mar 14, 2025Form D/A
$12.8M/ no target

Works with

Also named on Chimeron Bio filings

Kevin HeyeckChief Executive Officer, Form D signerForm D signer Afshin SafaviDirector Antonin de FougerollesDirector